IP Library Granted Patent US 8,293,790
Granted Patent B2
US 8,293,790 · App. 13/478,982 · Granted Oct 23, 2012

Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof

Assignee: Dignity Sciences Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,293,790
App. No.
13/478,982
Granted
Oct 23, 2012
Kind
B2
Abstract

The present disclosure provides compositions comprising fatty acids, or derivatives thereof (e.g., C1-C4 esters) including, for example, DGLA, 15-OHEPA and/or 15-HETrE, used singly or in combination with anti-bacterial agents for the treatment of disease and/or disorders such as acne or atopic dermatitis.

Claims (11)

1. A topically deliverable pharmaceutical composition comprising a therapeutically effective amount of dihomo-gamma-linolenic acid and benzoyl peroxide.

2. The pharmaceutical composition of claim 1 , wherein the pharmaceutical composition comprises about 1.25 wt. % to about 10 wt. % of benzoyl peroxide.

3. The pharmaceutical composition of claim 1 , wherein the pharmaceutical composition comprises about 0.1 wt. % to about 20 wt. % of dihomo-gamma-linolenic acid.

4. The pharmaceutical composition of claim 1 , wherein the composition is a cream.

5. A method of treating or inhibiting development of acne in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of the pharmaceutical composition of claim 1 .

6. The method of claim 5 , wherein the step of administering comprises applying the pharmaceutical composition to an area of skin of the subject afflicted with acne lesions.

7. The method of claim 5 , wherein the acne is associated with Propionibacterium acnes.

8. The method of claim 5 , wherein the pharmaceutical composition is administered to the subject once a day, twice a day, or three times a day.

9. The method of claim 5 , wherein the pharmaceutical composition is a cream.

10. The method of claim 5 , wherein the pharmaceutical composition comprises about 0.1 wt. % to about 20 wt. % of dihomo-gamma-linolenic acid.

11. The method of claim 5 , wherein the pharmaceutical composition comprises about 1.25 wt. % to about 10 wt. % of benzoyl peroxide.

Assignments (2)
CHANGE OF NAME Recorded Jul 31, 2017
From: DIGNITY SCIENCES LIMITED
To: DS BIOPHARMA LIMITED
Reel/Frame 043147/0143 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 22, 2012
From: MANKU, MEHAR; CLIMAX, JOHN; COUGHLAN, DAVID
To: DIGNITY SCIENCES LIMITED
Reel/Frame 028429/0001 →
Continuity (2)
Provisional Application 61549018 · Oct 19, 2011
Related Publication 20120232147A1 · Sep 13, 2012